Elliot Sigal, Director at Spark Therapeutics, Inc. (ONCE), bought 29 shares at $90.75 ($3K) on 2017-10-12, disclosed to the SEC on 2018-04-16.
Open-market purchase of $3k ONCE by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| Filing → |
| BMY | SELL | 2013-05-31 | $6.8M | — | Filing → |
| BMY | SELL | 2013-05-01 | $19.3M | — | Filing → |
| BMY | SELL | 2013-02-11 | $8.3M | — | Filing → |